P. Callegari

Complementary studies of the gastrointestinal safety of the cyclo‐oxygenase‐2‐selective inhibitor etoricoxib

Richard H. Hunt, S. E. Harper, P. Callegari et al. · Alimentary Pharmacology & Therapeutics · 2003 · 106 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study

D E Furst, Norman Gaylis, Vance J. Bray et al. · Annals of the Rheumatic Diseases · 2007 · 103 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis

Boxiong Tang, Mirza I. Rahman, Heidi C. Waters et al. · Clinical Therapeutics · 2008 · 102 citations

Life Sciences, Immunology, Pharmacotherapy +14

A multicenter, randomized, open study to evaluate the impact of an electronic data capture system on the care of patients with rheumatoid arthritis

J. Eugene Huffstutter, W. David Craig, Gregory F. Schimizzi et al. · Current Medical Research and Opinion · 2007 · 11 citations

Pharmacy, Biomedical Informatics, Health Informatics +17